Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blinding01:11

Blinding

2.9K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptation of visual responses in degenerating <i>rd10</i> and healthy mouse retinas during ongoing electrical stimulation.

Frontiers in neuroscience·2026
Same author

Longitudinal Changes of Fundus Autofluorescence and Correlation With Visual Acuity in ABCA4-Associated Stargardt Disease.

Investigative ophthalmology & visual science·2026
Same author

Surgical Approach for the Implantation of a Ring Electrode into the Sulcus in a Phakic Non-human Primate.

Journal of refractive surgery (Thorofare, N.J. : 1995)·2026
Same author

Real-Time Control of a Focus Tunable Lens for Presbyopia Correction Using Ciliary Muscle Biopotentials and Artificial Neural Networks.

Bioengineering (Basel, Switzerland)·2025
Same author

Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trial.

The British journal of ophthalmology·2025
Same author

Fast ERG 15 Hz flicker protocol for assessing functional changes in the rod system.

Documenta ophthalmologica. Advances in ophthalmology·2025

Related Experiment Video

Updated: May 6, 2026

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.2K

Fighting blindness with microelectronics.

Eberhart Zrenner1

  • 1Institute for Ophthalmic Research, Eberhard Karls University of Tübingen, D-72076 Tübingen, Germany.

Science Translational Medicine
|November 8, 2013
PubMed
Summary
This summary is machine-generated.

Restoring vision through retinal implants shows promise for photoreceptor degeneration blindness. This perspective explores optimal device placement, improved resolution, and safety for future visual prosthetics.

More Related Videos

Electrophysiological Characterization of GFP-Expressing Cell Populations in the Intact Retina
07:30

Electrophysiological Characterization of GFP-Expressing Cell Populations in the Intact Retina

Published on: November 14, 2011

15.3K
Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles
11:54

Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles

Published on: March 13, 2017

8.8K

Related Experiment Videos

Last Updated: May 6, 2026

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.2K
Electrophysiological Characterization of GFP-Expressing Cell Populations in the Intact Retina
07:30

Electrophysiological Characterization of GFP-Expressing Cell Populations in the Intact Retina

Published on: November 14, 2011

15.3K
Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles
11:54

Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles

Published on: March 13, 2017

8.8K

Area of Science:

  • Ophthalmology
  • Biomedical Engineering
  • Neuroscience

Background:

  • Degeneration of retinal photoreceptor cells causes irreversible blindness.
  • Microelectronic retinal implants offer a potential avenue for vision restoration.

Purpose of the Study:

  • To review the current state of retinal implant technology.
  • To address key challenges and outstanding questions in the field.

Main Methods:

  • This perspective discusses existing research and clinical progress in retinal implants.
  • It analyzes critical aspects such as optimal implant location and device design.

Main Results:

  • Current retinal implant technology shows encouraging progress in vision restoration.
  • Significant challenges remain regarding spatial/temporal resolution, safety, and longevity.

Conclusions:

  • Further research is needed to optimize retinal implant performance and patient outcomes.
  • Addressing questions of implant location, resolution, and safety is crucial for advancing visual prosthetics.